Globe Life exec exercises options, sells 10K shares

After the exercise, the reported employee stock-option position was 23,000 shares, and the two sales were listed at different per-share prices.

Rhea-AI Filing Summary

Globe Life Inc. EVP & Chief Investment Officer Robert Edward Hensley exercised 10,000 employee stock options on September 22, 2026, at an exercise price of $103.23, acquiring 10,000 common shares. On the same date, he sold 3,344 shares at a reported $169.5311 per share and 6,656 shares at $170.3409 per share; the respective sale ranges were $168.89 to $169.885 and $169.905 to $170.87. His reported post-transaction employee stock-option position was 23,000, and no Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and Sale: 10,000 shares ($668K approx. pre-tax spread)

Exercise and Sale 5 txns

Insider Hensley Robert Edward

Role EVP & Chief Investment Officer

Sold 10,000 shs ($1.70M)

Approx. gross sale proceeds $1.70M

Approx. exercise cost $1.03M

Approx. pre-tax spread $668K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	10,000	$0.00	$0.00
Exercise	Common Stock	10,000	$103.23	$1.03M
Sale	Common Stock F1, F2	3,344	$169.5311	$567K
Sale	Common Stock F1, F3	6,656	$170.3409	$1.13M
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 23,000 contracts (Direct); Common Stock — 12,383.9885 shares (Direct); Common Stock — 0 shares (Indirect, Not Applicable)

Footnotes (3)

1. F1. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
2. F2. Sales at prices ranging from $168.89 per share to $169.885 per share.
3. F3. Sales at prices ranging from $169.905 per share to $170.87 per share.

Key Figures

Employee stock options exercised: 10,000 options Exercise price: $103.23 per share Common shares acquired: 10,000 shares +3 more

6 metrics

Employee stock options exercised 10,000 options September 22, 2026

Exercise price $103.23 per share Options exercised September 22, 2026

Common shares acquired 10,000 shares September 22, 2026

Shares sold 3,344 shares Reported per-share price: $169.5311; sale range: $168.89 to $169.885

Shares sold 6,656 shares Reported per-share price: $170.3409; sale range: $169.905 to $170.87

Reported post-transaction employee stock-option position 23,000 options Following the September 22, 2026 transaction

Key Terms

Employee Stock Option (Right to Buy), exercise price, Rule 10b5-1 plan

3 terms

Employee Stock Option (Right to Buy) financial

"10,000 Employee Stock Option (Right to Buy)"

exercise price financial

"at an exercise price of $103.23"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Rule 10b5-1 plan regulatory

"no Rule 10b5-1 plan is reported"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Globe Life (GL) EVP Robert Edward Hensley report on September 22, 2026?

He exercised 10,000 employee stock options at an exercise price of $103.23, acquired 10,000 common shares, and sold 10,000 common shares in two reported transactions.

How many GL shares did Robert Edward Hensley sell, and at what prices?

He sold 3,344 shares at a reported $169.5311 per share, with sales ranging from $168.89 to $169.885, and 6,656 shares at $170.3409 per share, with sales ranging from $169.905 to $170.87.

How many employee stock options did the Globe Life executive have after the exercise?

The reported post-transaction position was 23,000 employee stock options.

Were the Globe Life transactions reported under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 12:24 PM Accepted by SEC EDGAR 09/23/2026 - 12:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hensley Robert Edward

(Last) (First) (Middle)

GLOBE LIFE INC.

7677 HENNEMAN WAY

(Street)

MCKINNEY TEXAS 75070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GLOBE LIFE INC. [ GL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Investment Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/22/2026		M		10,000	A	$103.23	22,383.9885	D
Common Stock	09/22/2026		S		3,344	D	$169.5311	19,039.9885(1)(2)	D
Common Stock	09/22/2026		S		6,656	D	$170.3409	12,383.9885(1)(3)	D
Common Stock								0	I	Not Applicable

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$103.23	09/22/2026		M			10,000	02/23/2025	02/23/2029	Common Stock	10,000	$0	23,000	D

Explanation of Responses:

1. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

2. Sales at prices ranging from $168.89 per share to $169.885 per share.

3. Sales at prices ranging from $169.905 per share to $170.87 per share.

	Robert Edward Hensley by /s/ Chris T. Moore, Attorney-in-fact	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)